The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patterns of relapse and implications for post-nephrectomy surveillance for patients with high-risk non-clear cell renal cell carcinoma: Subgroup analysis of the phase 3 ECOG-ACRIN E2805 trial.
 
Vivek Narayan
Consulting or Advisory Role - Exelixis
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline
 
Maneka Puligandla
No Relationships to Disclose
 
Pearl Subramanian
No Relationships to Disclose
 
Robert Uzzo
Consulting or Advisory Role - Genentech/Roche; Johnson & Johnson; Pfizer
Speakers' Bureau - Janssen Oncology
Research Funding - Novartis
 
Robert S. DiPaola
No Relationships to Disclose
 
Naomi B. Haas
Consulting or Advisory Role - Cerulean Pharma; Exelixis; Janssen Oncology; Novartis; Pfizer
Expert Testimony - Lilly (I)